MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

Q: What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in Q1 2020?

106 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 558868105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 22,822,754
Total 13F shares: 11,048,035
Share change: +610,369
Total reported value: $737,557,931
Put/Call ratio: 441%
Price per share: $66.76
Number of holders: 106
Value change: +$26,608,051
Number of buys: 58
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 558868105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	7.4%	1,697,119	$154,625,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	5.1%	1,169,278	$106,533,000	—	31 Dec 2019	13F
HealthCor Management, L.P.	13F	Company	4.8%	1,088,310	$99,156,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.2%	957,146	$87,205,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	3.4%	785,441	$71,561,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	2.5%	579,780	$52,824,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	2%	458,378	$41,763,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.5%	351,641	$32,038,000	—	31 Dec 2019	13F
Avoro Capital Advisors LLC	13F	Company	1.5%	349,000	$31,797,000	—	31 Dec 2019	13F
JENNISON ASSOCIATES LLC	13F	Company	1.2%	276,430	$25,186,000	—	31 Dec 2019	13F
Rock Springs Capital Management LP	13F	Company	1.1%	250,200	$22,796,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.81%	185,544	$16,904,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.72%	164,801	$15,015,000	—	31 Dec 2019	13F
ARMISTICE CAPITAL, LLC	13F	Company	0.7%	160,000	$14,578,000	—	31 Dec 2019	13F
Laurion Capital Management LP	13F	Company	0.6%	135,797	$12,372,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	0.56%	128,545	$11,712,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.54%	123,933	$11,291,000	—	31 Dec 2019	13F
LUMINUS MANAGEMENT LLC	13F	Company	0.54%	122,833	$11,191,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.42%	95,725	$8,722,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.35%	80,466	$7,329,000	—	31 Dec 2019	13F
HBK INVESTMENTS L P	13F	Company	0.33%	75,000	$6,833,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.25%	57,337	$5,224,000	—	31 Dec 2019	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.24%	55,365	$5,044,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	54,809	$4,994,000	—	31 Dec 2019	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.24%	54,200	$4,938,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.21%	47,419	$4,320,000	—	31 Dec 2019	13F
Ikarian Capital, LLC	13F	Company	0.2%	44,770	$4,079,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.18%	41,609	$3,791,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.18%	40,950	$3,731,000	—	31 Dec 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.18%	40,000	$3,644,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.15%	34,241	$3,120,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.15%	34,173	$3,113,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	33,173	$3,023,000	—	31 Dec 2019	13F
ALPS ADVISORS INC	13F	Company	0.14%	31,020	$2,826,000	—	31 Dec 2019	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.13%	28,561	$2,602,000	—	31 Dec 2019	13F
MACQUARIE GROUP LTD	13F	Company	0.12%	28,500	$2,597,000	—	31 Dec 2019	13F
Logos Global Management LP	13F	Company	0.12%	27,279	$2,485,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.1%	23,664	$2,156,000	—	31 Dec 2019	13F
Capital Impact Advisors, LLC	13F	Company	0.1%	23,355	$2,128,000	—	31 Dec 2019	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.1%	22,071	$2,011,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.1%	21,798	$1,986,000	—	31 Dec 2019	13F
Squarepoint Ops LLC	13F	Company	0.09%	21,301	$1,941,000	—	31 Dec 2019	13F
AVIVA PLC	13F	Company	0.08%	19,151	$1,745,000	—	31 Dec 2019	13F
Pinz Capital Management, LP	13F	Company	0.08%	18,695	$1,703,000	—	31 Dec 2019	13F
Magnus Financial Group LLC	13F	Company	0.08%	17,413	$1,586,000	—	31 Dec 2019	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.08%	17,400	$1,585,000	—	31 Dec 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.07%	16,500	$1,503,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.07%	16,200	$1,476,000	—	31 Dec 2019	13F
Rafferty Asset Management, LLC	13F	Company	0.07%	15,679	$1,429,000	—	31 Dec 2019	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.07%	15,423	$1,405,000	—	31 Dec 2019	13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q1 2020

As of 31 Mar 2020, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,048,035 shares. The largest 10 holders included Capital Research Global Investors, BAKER BROS. ADVISORS LP, HealthCor Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, ALLIANCEBERNSTEIN L.P., Avoro Capital Advisors LLC, and Rock Springs Capital Management LP. This page lists 106 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

119

Q1 2020 holders

106

Holder diff

-13

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.